# BOHE Angel Fund

> BOHE Angel Fund is a VC fund in Suzhou backing Health Care, Medical and Biotechnology. See 16 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Suzhou, China
- Total investments: 16
- Last investment: Mar 2026
- Lead investor: 19%
- Last updated: Aug 2026

BOHE Angel Fund is an investment Fund.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $14M–$15M |
| Angel | $1.4M–$100M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 9 | 56% |
| Medical | 6 | 38% |
| Biotechnology | 5 | 31% |
| Life Science | 2 | 13% |
| Pharmaceutical | 2 | 13% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Angel | 6 | 38% |
| Seed | 4 | 25% |
| Series A | 3 | 19% |
| Series B | 1 | 6% |
| Venture - Series Unknown | 1 | 6% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| PrinoPharma | PrinoPharma focuses on developing novel druggable sites targeting difficult-to-drug or existing druggable targets. | $14.5M | Angel | Mar 10, 2026 |  |
| Qinhao Pharmaceutical | Qinhao Pharmaceutical is harmaceutical enterprises with a gathering of humanities and innovation. | $43M | Venture - Series Unknown | Jan 13, 2026 |  |
| KangaBio | KangaBio is a biotech business specializing in developing novel medicines to meet unmet medical needs. It helps in developing prodrugs of immune-stimulating medicines and other multi-specific biologics to minimize toxicities and boost treatment efficacy for already established targets. | $15M | Seed | Dec 01, 2025 |  |
| Yili Pharmaceutical | Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development. | $14M | Angel | Sep 25, 2025 |  |
| Yuanke Medical | Yuanke Medical is a company focused on medical device operations and technical services. Its core activities include R&D, sales, and support for medical devices, providing high-quality solutions to healthcare institutions. |  | Seed | Aug 19, 2025 |  |
| Yili Pharmaceutical | Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development. | $100M | Angel | Dec 24, 2024 |  |
| Yili Pharmaceutical | Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development. | $13.7M | Seed | Dec 24, 2024 |  |
| QuarkMed | QuarkMed is a nuclear medicine clinical CRO service company. |  | Series A | Oct 11, 2024 |  |
| Tyligand Bioscience | Tyligand Bioscience is a biotechnology company that focuses on the discovery and development of small molecule therapeutics to help patients with cancer and autoimmune diseases. Tyligand's pharmaceuticals are designed to target and treat tumors and autoimmune disorders, enabling healthcare professionals to prescribe more effective medicine andimprove health outcomes. |  | Series A | Jul 08, 2023 |  |
| Levostar | Levostar is a biotechnology company that specializes in the development and manufacture of cell and gene therapy products. |  | Seed | Apr 11, 2022 |  |

10 of 16 investments shown.

## Co-investors
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 3 deals together
- [Qingsong Capital](https://shizune.co/investors/profile/qingsong-capital) — VC Fund, 3 deals together
- [Huagai Capital](https://shizune.co/investors/profile/huagai-capital) — VC Fund, 2 deals together
- [Lula Capital](https://shizune.co/investors/profile/lula-capital) — VC Fund, 2 deals together
- [TaiKun Fund](https://shizune.co/investors/profile/taikun-fund) — VC Fund, 2 deals together
- [Tailong Investment](https://shizune.co/investors/profile/tailong-investment) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [LVX Ventures](https://shizune.co/investors/profile/letsventure) — VC Fund
- [ZhenFund](https://shizune.co/investors/profile/zhenfund) — VC Fund
- [IAN Group](https://shizune.co/investors/profile/indian-angel-network) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [East Ventures](https://shizune.co/investors/profile/east-ventures) — VC Fund
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund

## Featured in investor lists
- [Life Science Investors in Asia](https://shizune.co/investors/life-science-investors-asia)
- [Life Science Investors in China](https://shizune.co/investors/life-science-investors-china)
- [Life Science VC Funds in Asia](https://shizune.co/investors/life-science-vc-funds-asia)
- [Life Science VC Funds in China](https://shizune.co/investors/life-science-vc-funds-china)

## FAQ

### What does BOHE Angel Fund invest in?

BOHE Angel Fund invests primarily in Health Care, Medical and Biotechnology startups, most often at Angel and Seed stage. Most of the 16 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is BOHE Angel Fund's check size?

BOHE Angel Fund typically joins rounds of $14M–$15M at Seed and $1.4M–$100M at Angel. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds BOHE Angel Fund participates in.

### When did BOHE Angel Fund last invest?

The most recent investment recorded for BOHE Angel Fund closed in Mar 2026. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co